Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Top Buzzing Stocks

    Jump to

    • Lupin shares gain on USGFA approval for Raltegravir tablets

      Lupin Share Price | Lupin is the exclusive first-to-file for this product and is eligible for 180 days of generic drug exclusivity. This product will be manufactured at Lupin’s Nagpur facility in India.

    • Ahluwalia Contracts shares hit 52-week high on order win from Airports Authority of India

      Ahluwalia Contracts Share Price | The contract is worth of Rs 572 crore and to be executed in 24 months.

    • UFO Moviez opens 5% higher on alliance with TSR Films for advertising rights

      The share touched a 52-week high of Rs 148.05 and a 52-week low of Rs 57.30 on 10 January, 2024 and 28 March, 2023, respectively.

    • Inox Wind shares gain 2% on winning 279 MW order from C&I player

      The project will be executed by June 2025, with the WTGs being installed across Rajasthan and Gujarat.

    • Man Industries shares hit 52-week high on winning Rs 380-cr order for pipes

    • Oberoi Realty shares gain on divesting entire stake in JV company

      The share touched a 52-week high of Rs 1,206.00 and a 52-week low of Rs 790.05 on September 11, 2023, and January 27, 2023, respectively.

    • Granules India gets USFDA nod for Gabapentin Tablets; share price falls

    • Lupin gets tentative USFDA approval for obeticholic acid tablets, shares gain

    • Maruti Suzuki Q3 profit zooms 130%; what should investors do now?

    • Siemens stock gains on winning order from Indian Railways

    • HCL Tech in the spotlight after results: Should you buy, sell or hold?

    • Natco Pharma gains after court waves through insecticide launch

    • Bajaj Finance on fire, top contributor to Sensex rally as Q1 profit soars 159%

    • Bajaj Auto after a fair show in Q1: Should you buy, sell or hold the stock?

    • PVR turns profitable in Q1: What investors should do with stock now

    • IndusInd Bank shares gain 7% after profit jumps 60% in Q1

    • Aurobindo Pharma hits 52-week low after six observations from US

    • Asian Paints rises 3% ahead of results

    • Mindtree has reported earnings | Should investors buy, sell or hold stock?

    • HDFC Bank after Q4 Earnings | What should investors do: Buy, sell, or hold?

    • Hikal declines 11% after unit gets closure notice from Maharashtra Pollution Control Board

    • ACC share price rises on capacity expansion, KRChoksey upgrades to 'buy'

    • What should investors do with HDFC Bank after Q3 earnings; buy, sell or hold?

    • JBM Auto shares hit 5% upper circuit after subsidiary picks up 51% in group firms

    • Tata Motors share price slips 1% after CLSA cuts rating, lowers target price

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347